S. Rizvi

Molecular characterization of SARS-CoV-2 from Bangladesh: implications in genetic diversity, possible origin of the virus, and functional significance of the mutations

M. Rahman, S. Kader, S. Rizvi, 2021, Heliyon.

Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

C. Goss, P. Burgel, M. Salvatore, 2020, Journal of Cystic Fibrosis.

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

C. Goss, H. Rodgers, P. Burgel, 2022, Journal of Cystic Fibrosis.

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

C. Goss, H. Rodgers, P. Burgel, 2020, Journal of Cystic Fibrosis.

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

C. Goss, H. Rodgers, P. Burgel, 2020, Journal of Cystic Fibrosis.

The findings of Antimicrobial Resistance Surveillance in Bangladesh (2016-2020)

Nazmun Nahar Bably, I. A. Khan, S. Rizvi, 2021, medRxiv.

COVID-19 vaccine prioritisation for people with cystic fibrosis

C. Goss, P. Burgel, M. Salvatore, 2021, Journal of Cystic Fibrosis.